ITGAE and neoplasm: Resistance to targeted therapy in melanoma leads to activation of a cancer cell-intrinsic signaling program with enhanced and altered transcriptional output associated with an immunosuppressive tumor microenvironment, characterized by a lack of functional CD103+ DCs and T cells.